270 participants
Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-15
- Start Date:
- 2026-07-20
- Completion:
- 2033-09-15
Conditions
- Alpha1 Antitrypsin Deficiency
- Alpha1-Proteinase Inhibitor Deficiency
- Emphysema
Interventions
- BIOLOGICAL
No Results Yet